Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fibromyalgia study reveals muscle and sleep clues in women

NCT ID NCT07649824

Knowledge-focused Sponsor: Kirsehir Ahi Evran Universitesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared 80 women with and without fibromyalgia to measure muscle strength, muscle thickness, vitamin D levels, and sleep quality. Researchers used advanced tools like isokinetic dynamometers and ultrasound to find differences between the groups. The goal was to better understand fibromyalgia's impact and identify possible risk factors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help identify key physical and biochemical factors linked to fibromyalgia, guiding future treatments.
What could go wrong
This is a small, completed observational study, not a treatment trial. Results may not apply to all fibromyalgia patients or lead to direct therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

80 people

The number who actually took part.

Started

Apr 2024

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The case group consisted of 40 volunteer female patients who presented to the outpatient clinic of the university hospital, agreed to participate in the study, were diagnosed with fibromyalgia syndrome, and met the inclusion criteria. The control group consisted of 40 healthy female volunteers who did not have a diagnosis of fibromyalgia syndrome

Ages

18 to 55 years

Sex

Female participants only

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patient group: * female gender * 18-55 years old * Clinical diagnosis of Fibromyaljia syndrome Control group: * female gender * 18-55 years old * absence of fibromyalgia syndrome diagnosis Exclusion Criteria: * Rheumatological disease, crystal arthropathy, septic arthritis * Advanced osteoarthritis * History of major orthopedic surgery (total knee and hip replacement, etc.) * Neurological disease (Parkinson's disease, multiple sclerosis, cerebrovascular event, etc.) * Neuromuscular disease (Polyneuropathies, myasthenia gravis) * Active malignancy * Advanced organ failure/transplantation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic pain syndrome fibromyalgia muscular atrophy sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain syndrome Fibromyalgia Muscle thinning Sleep Vitamin D3

Contacts and locations

Locations

  • Kırşehir Ahi Evran University Faculty of Medicine

    Kırşehir, City Center, 40100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.